Canada markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.75-0.45 (-1.04%)
At close: 04:00PM EDT
43.58 +0.83 (+1.94%)
After hours: 05:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.55B
Enterprise Value 3.02B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.24
Price/Book (mrq)12.90
Enterprise Value/Revenue 6.95
Enterprise Value/EBITDA -5.85

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-8.18%
S&P500 52-Week Change 322.38%
52 Week High 354.98
52 Week Low 331.52
50-Day Moving Average 347.43
200-Day Moving Average 342.11

Share Statistics

Avg Vol (3 month) 3717.47k
Avg Vol (10 day) 3745.24k
Shares Outstanding 583.13M
Implied Shares Outstanding 683.13M
Float 872.27M
% Held by Insiders 14.02%
% Held by Institutions 1100.16%
Shares Short (Apr 15, 2024) 44.38M
Short Ratio (Apr 15, 2024) 46.09
Short % of Float (Apr 15, 2024) 46.15%
Short % of Shares Outstanding (Apr 15, 2024) 45.27%
Shares Short (prior month Mar 15, 2024) 43.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -138.58%
Operating Margin (ttm)-151.93%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)442.59M
Revenue Per Share (ttm)5.75
Quarterly Revenue Growth (yoy)8.30%
Gross Profit (ttm)N/A
EBITDA -553.18M
Net Income Avi to Common (ttm)-613.35M
Diluted EPS (ttm)-8.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)339.39%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)3.35

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A